Literature DB >> 27914234

Food, gastrointestinal pH, and models of oral drug absorption.

Ahmad Y Abuhelwa1, Desmond B Williams2, Richard N Upton3, David J R Foster4.   

Abstract

This article reviews the major physiological and physicochemical principles of the effect of food and gastrointestinal (GI) pH on the absorption and bioavailability of oral drugs, and the various absorption models that are used to describe/predict oral drug absorption. The rate and extent of oral drug absorption is determined by a complex interaction between a drug's physicochemical properties, GI physiologic factors, and the nature of the formulation administered. GI pH is an important factor that can markedly affect oral drug absorption and bioavailability as it may have significant influence on drug dissolution & solubility, drug release, drug stability, and intestinal permeability. Different regions of the GI tract have different drug absorptive properties. Thus, the transit time in each GI region and its variability between subjects may contribute to the variability in the rate and/or extent of drug absorption. Food-drug interactions can result in delayed, decreased, increased, and sometimes un-altered drug absorption. Food effects on oral absorption can be achieved by direct and indirect mechanisms. Various models have been proposed to describe oral absorption ranging from empirical models to the more sophisticated "mechanism-based" models. Through understanding of the physicochemical and physiological rate-limiting factors affecting oral absorption, modellers can implement simplified population-based modelling approaches that are less complex than whole-body physiologically-based models but still capture the essential elements in a physiological way and hence will be more suited for population modelling of large clinical data sets. It will also help formulation scientists to better predict formulation performance and to develop formulations that maximize oral bioavailability.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Empirical absorption models; Food-drug interactions; Gastrointestinal pH; Physiologically-based pharmacokinetic (PBPK) models; Predicting oral absorption

Mesh:

Year:  2016        PMID: 27914234     DOI: 10.1016/j.ejpb.2016.11.034

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  21 in total

1.  Gastrointestinal pH, Motility Patterns, and Transit Times After Roux-en-Y Gastric Bypass.

Authors:  Louise Ladebo; Pernille V Pedersen; Grzegorz J Pacyk; Jens Peter Kroustrup; Asbjørn M Drewes; Christina Brock; Anne E Olesen
Journal:  Obes Surg       Date:  2021-03-12       Impact factor: 4.129

2.  Food, Acid Supplementation and Drug Absorption - a Complicated Gastric Mix: a Randomized Control Trial.

Authors:  Dalga D Surofchy; Lynda A Frassetto; Leslie Z Benet
Journal:  Pharm Res       Date:  2019-09-04       Impact factor: 4.200

3.  Effects of food and grapefruit juice on single-dose pharmacokinetics of blonanserin in healthy Chinese subjects.

Authors:  De-Wei Shang; Zhan-Zhang Wang; Hai-Tang Hu; Yue-Feng Zhang; Xiao-Jia Ni; Hao-Yang Lu; Ming Zhang; Jin-Qing Hu; Chang Qiu; Huan Peng; Ling-Fang Shen; Yu-Guan Wen
Journal:  Eur J Clin Pharmacol       Date:  2017-10-03       Impact factor: 2.953

Review 4.  Predicting Oral Drug Absorption: Mini Review on Physiologically-Based Pharmacokinetic Models.

Authors:  Louis Lin; Harvey Wong
Journal:  Pharmaceutics       Date:  2017-09-26       Impact factor: 6.321

5.  Fused Deposition Modeling (FDM) 3D Printed Tablets for Intragastric Floating Delivery of Domperidone.

Authors:  Xuyu Chai; Hongyu Chai; Xiaoyu Wang; Jingjing Yang; Jin Li; Yan Zhao; Weimin Cai; Tao Tao; Xiaoqiang Xiang
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

6.  Spatial and Temporal Analysis of the Stomach and Small-Intestinal Microbiota in Fasted Healthy Humans.

Authors:  Anna M Seekatz; Matthew K Schnizlein; Mark J Koenigsknecht; Jason R Baker; William L Hasler; Barry E Bleske; Vincent B Young; Duxin Sun
Journal:  mSphere       Date:  2019-03-13       Impact factor: 4.389

7.  The Effect Of Food On The Pharmacokinetic Properties And Bioequivalence Of Two Formulations Of Levocetirizine Dihydrochloride In Healthy Chinese Volunteers.

Authors:  Yu Cheng; Bi-Juan Lin; Jin-Hua Guo; Bing-Lin Huang; Lin-Ping Fang; Wan-Cai Que; Mao-Bai Liu; Xin-Feng Chen; Hong-Qiang Qiu
Journal:  Drug Des Devel Ther       Date:  2019-10-18       Impact factor: 4.162

8.  Identification of Abies sibirica L. Polyprenols and Characterisation of Polyprenol-Containing Liposomes.

Authors:  Ilona Vanaga; Jerzy Gubernator; Ilva Nakurte; Ugis Kletnieks; Ruta Muceniece; Baiba Jansone
Journal:  Molecules       Date:  2020-04-14       Impact factor: 4.411

9.  First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates.

Authors:  Janneke M Brussee; Huixin Yu; Elke H J Krekels; Berend de Roos; Margreke J E Brill; Johannes N van den Anker; Amin Rostami-Hodjegan; Saskia N de Wildt; Catherijne A J Knibbe
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-05-10

10.  Identification of beagle food taking patterns and protocol for food effects evaluation on bioavailability.

Authors:  Guoqing Zhang; Caifen Wang; Li Wu; Jian Xu; Xiaoxiao Hu; Shailendra Shakya; Yuanzhi He; Xiaohong Ren; Weidong Chen; Jiwen Zhang
Journal:  Sci Rep       Date:  2018-08-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.